185 related articles for article (PubMed ID: 32301558)
1. An application of the Toronto Childhood Cancer Stage Guidelines in three population-based cancer registries: The case of central nervous tumors.
Sacerdote C; Mosso ML; Alessi D; Merletti F; Tagliabue G; D'Agostino A; Fabiano S; Savoia F; Piga P; Sessa M; Vetrano F; Gatta G; Maule M
Pediatr Blood Cancer; 2020 Jun; 67(6):e28303. PubMed ID: 32301558
[TBL] [Abstract][Full Text] [Related]
2. Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study.
Aitken JF; Youlden DR; Moore AS; Baade PD; Ward LJ; Thursfield VJ; Valery PC; Green AC; Gupta S; Frazier AL
Lancet Child Adolesc Health; 2018 Mar; 2(3):173-179. PubMed ID: 30169253
[TBL] [Abstract][Full Text] [Related]
3. Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry.
Youlden DR; Gupta S; Frazier AL; Moore AS; Baade PD; Valery PC; Green AC; Aitken JF
Pediatr Blood Cancer; 2019 Jun; 66(6):e27683. PubMed ID: 30803139
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
5. International benchmarking of childhood cancer survival by stage at diagnosis: The BENCHISTA project protocol.
Botta L; Gatta G; Didonè F; Lopez Cortes A; Pritchard-Jones K;
PLoS One; 2022; 17(11):e0276997. PubMed ID: 36327231
[TBL] [Abstract][Full Text] [Related]
6. Registration, incidence patterns, and survival trends of central nervous system tumors among children in Germany 1980-2019: An analysis of 40 years based on data from the German Childhood Cancer Registry.
Wellbrock M; Voigt M; Ronckers C; Grabow D; Spix C; Erdmann F
Pediatr Blood Cancer; 2024 Jun; 71(6):e30954. PubMed ID: 38532243
[TBL] [Abstract][Full Text] [Related]
7. Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.
Gittleman H; Cioffi G; Vecchione-Koval T; Ostrom QT; Kruchko C; Osorio DS; Finlay JL; Barnholtz-Sloan JS
J Neurooncol; 2019 Jun; 143(2):251-260. PubMed ID: 31025275
[TBL] [Abstract][Full Text] [Related]
8. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
9. Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study.
Magnani C; Aareleid T; Viscomi S; Pastore G; Berrino F;
Eur J Cancer; 2001 Apr; 37(6):711-21. PubMed ID: 11311645
[TBL] [Abstract][Full Text] [Related]
10. Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.
Truitt G; Gittleman H; Leece R; Ostrom QT; Kruchko C; Armstrong TS; Gilbert MR; Barnholtz-Sloan JS
J Neurooncol; 2019 Aug; 144(1):53-63. PubMed ID: 31209773
[TBL] [Abstract][Full Text] [Related]
11. Incidence and survival of central nervous system tumors in childhood and adolescence in Girona (Spain) 1990-2013: national and international comparisons.
Rivas-Vilela S; Rubió-Casadevall J; Fàbrega-Ribas A; Joly-Torta C; Vilardell L; Marcos-Gragera R
Clin Transl Oncol; 2019 Sep; 21(9):1177-1185. PubMed ID: 30712237
[TBL] [Abstract][Full Text] [Related]
12. Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes.
Pongtanakul B; Sirachainan N; Surapolchai P; Charoenkwan P; Choeyprasert W; Komwilaisak P; Chainansamit SO; Witsanuyothin N; Lertrakul Y; Rujkijyanont P; Kanjanapongkul S; Sosothikul D; Sanpakit K; Chotsampancharoen T; Wangruangsathit S; Thokanit NS; Tabjareon S; Hongeng S
J Neurooncol; 2020 Aug; 149(1):141-151. PubMed ID: 32710301
[TBL] [Abstract][Full Text] [Related]
13. Brain and other central nervous system tumor statistics, 2021.
Miller KD; Ostrom QT; Kruchko C; Patil N; Tihan T; Cioffi G; Fuchs HE; Waite KA; Jemal A; Siegel RL; Barnholtz-Sloan JS
CA Cancer J Clin; 2021 Sep; 71(5):381-406. PubMed ID: 34427324
[TBL] [Abstract][Full Text] [Related]
14. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
Georgakis MK; Papathoma P; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Themistocleous M; Tolia M; Tzanis S; Alexiou GA; Papanikolaou PG; Nomikos P; Kantzanou M; Dessypris N; Pourtsidis A; Petridou ET
Cancer; 2017 Nov; 123(22):4458-4471. PubMed ID: 28708937
[TBL] [Abstract][Full Text] [Related]
15. Birth seasonality of childhood central nervous system tumors: Analysis of primary data from 16 Southern-Eastern European population-based registries.
Karalexi MA; Dessypris N; Georgakis MK; Ryzhov A; Jakab Z; Zborovskaya A; Dimitrova N; Zivkovic S; Trojanowski M; Sekerija M; Antunes L; Zagar T; Eser S; Bastos J; Demetriou A; Agius D; Coza D; Gheorghiu R; ; Kantzanou M; Ntzani EE; Petridou ET
Int J Cancer; 2020 Sep; 147(5):1252-1263. PubMed ID: 31957026
[TBL] [Abstract][Full Text] [Related]
16. Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013).
Fuentes-Raspall R; Solans M; Roca-Barceló A; Vilardell L; Puigdemont M; Del Barco S; Comas R; García-Velasco A; Astudillo A; Carmona-Garcia MC; Marcos-Gragera R
Cancer Epidemiol; 2017 Oct; 50(Pt A):1-8. PubMed ID: 28738268
[TBL] [Abstract][Full Text] [Related]
17. Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study.
Stiller CA; Bayne AM; Chakrabarty A; Kenny T; Chumas P
BMC Cancer; 2019 Feb; 19(1):139. PubMed ID: 30744596
[TBL] [Abstract][Full Text] [Related]
18. Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.
Kenborg L; Winther JF; Linnet KM; Krøyer A; Albieri V; Holmqvist AS; Tryggvadottir L; Madanat-Harjuoja LM; Stovall M; Hasle H; Olsen JH;
Neuro Oncol; 2019 Jan; 21(1):125-136. PubMed ID: 29850875
[TBL] [Abstract][Full Text] [Related]
19. Survival trends of childhood cancer diagnosed during 1970-1994 in Piedmont, Italy: a report from the Childhood Cancer Registry.
Pastore G; Mosso ML; Carnevale F; di Montezemolo LC; Forni M; Madon E; Ricardi U; Terracini B; Magnani C
Med Pediatr Oncol; 2001 Apr; 36(4):481-8. PubMed ID: 11260572
[TBL] [Abstract][Full Text] [Related]
20. Stage at diagnosis for childhood solid cancers in Australia: A population-based study.
Youlden DR; Frazier AL; Gupta S; Pritchard-Jones K; Kirby ML; Baade PD; Green AC; Valery PC; Aitken JF
Cancer Epidemiol; 2019 Apr; 59():208-214. PubMed ID: 30831553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
